Lundbeck
HLUN-B.CO
#2487
Rank
HK$44.07 B
Marketcap
HK$46.04
Share price
2.10%
Change (1 day)
21.06%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Market capitalization of Lundbeck (HLUN-B.CO)

Market cap: HK$44.07 Billion

As of January 2025 Lundbeck has a market cap of HK$44.07 Billion. This makes Lundbeck the world's 2487th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Lundbeck from 2005 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$44.07 B1.85%
2024HK$43.26 B17.78%
2023HK$36.73 B30.1%
2022HK$28.23 B427.27%
2021HK$5.35 B-25.05%
2020HK$7.14 B-9.56%
2019HK$7.90 B-13.31%
2018HK$9.11 B-13.66%
2017HK$10.55 B25.49%
2016HK$8.41 B19%
2015HK$7.06 B72.3%
2014HK$4.10 B-20.69%
2013HK$5.17 B72.7%
2012HK$2.99 B-41.61%
2011HK$5.12 B32.62%
2010HK$3.86 B1.57%
2009HK$3.80 B-18.13%
2008HK$4.65 B-18.52%
2007HK$5.70 B-5.09%
2006HK$6.01 B25.34%
2005HK$4.79 B